homesite mapcontact us
 

 

Shareholder Information

Print Page Print | E-mail Page E-mail | RSS Feeds RSS
Webcast ImageWebcast
Q2 2010 Cambrex Earnings Conference Call (Live)
08/04/10 at 8:30 a.m. ET

Cambrex provides products and services to accelerate the development and commercialization of branded and generic small molecule therapeutics.

Stock Quote
CBM (Common Stock)
ExchangeNYSE (US Dollar)
Price$3.55
Change (%) Stock is Down 0.09 (2.47%)
Volume34,754
Data as of 07/30/10 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000CBM
Stock Exchange
New York Stock Exchange (NYSE)
Stock Symbol
CBM
Recent News more>>
DateTitle 
07/28/10Cambrex VP Featured in Drug Delivery Technology ArticlePrinter Friendly Version
07/26/10Cambrex to Announce Second Quarter 2010 Financial Results on August 3, 2010Printer Friendly Version
07/13/10Cambrex Featured In Manufacturing Today ArticlePrinter Friendly Version
06/17/10Dr. John Michnick Joins Cambrex Business Development TeamPrinter Friendly Version
Upcoming Events more>>
DateTitle
08/04/10 8:30 a.m. ET
Q2 2010 Cambrex Earnings Conference Call
Contact Information
Investor Relations Contact
Greg Sargen
Vice President and Chief Financial Officer
Phone: 201-804-3037
Fax: 201-804-9852
Email: gregory.sargen@cambrex.com

Transfer Agent
American Stock Transfer & Trust Company
40 Wall Street
New York, NY 10005
Phone: 800-937-5449
Email: info@amstock.com

Independent Accountants
BDO Seidman, LLP


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
 

Home | Products & Services | About Us | Careers | Investors | Site Map | Contact Us | 866.286.9133

 Legal  |  Privacy Policy |   Employee Log In web site built by Bower Web Solutions